Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Diana Shipping Director Reports Warrant Exercise

A Form 4 filed on September 18, 2026, by Anastasios Margaronis, a director of Diana Shipping Inc. (NYSE:DSX), discloses the exercise of 122,471 warrants by his spouse through an affiliated entity on September 17, 2026.

Manish Choudhary | 18 September 2026

Diana Shipping Director Sells 20,000 Warrants

A Form 4 filed on September 18, 2026 discloses that Eleftherios Papatrifon, a director of Diana Shipping Inc. (NYSE:DSX), sold 20,000 warrants on September 16 and 17, 2026 at an exercise price of $1.69527.

Shwetambri Chauhan | 18 September 2026

MapLight Therapeutics General Counsel Sells 16,509 Shares

Kristopher Hanson, General Counsel of MapLight Therapeutics, Inc. (NASDAQ:MPLT), filed a Form 4 on September 18, 2026, disclosing the sale of 16,509 shares of Voting Common Stock on September 16, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Aakashdeep | 18 September 2026

Avalo Therapeutics CFO Sells 12,394 Shares Under 10b5-1 Plan

Christopher Ryan Sullivan, Chief Financial Officer of Avalo Therapeutics, Inc. (NASDAQ:AVTX), filed a Form 4 on September 18, 2026, disclosing an option exercise and sale of common stock on September 16, 2026, executed under a pre-established Rule 10b5-1 trading plan.

Anjali Anand | 18 September 2026

Arcutis Biotherapeutics CLO Sells 3,674 Shares

Masaru Matsuda, Executive Vice President and Chief Legal Officer of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), filed a Form 4 on September 18, 2026, reporting the sale of 3,674 shares of common stock on September 16, 2026.

Aditi Sarkar | 18 September 2026

Palvella Therapeutics COO Sells Shares Under 10b5-1 Plan

Kathleen Goin, Chief Operating Officer of Palvella Therapeutics, Inc. (NASDAQ:PVLA), filed a Form 4 on September 18, 2026, reporting the exercise of stock options and subsequent sale of common shares on September 16, 2026, pursuant to a Rule 10b5-1 trading plan.

Aditi Sarkar | 18 September 2026

Aflac Officer Koide Masatoshi Reports Stock Sales and Option Exercise

Masatoshi Koide, President and Representative Director of Aflac Life Insurance Japan (ALIJ) and an officer of Aflac Incorporated (NYSE:AFL), filed a Form 4 on September 18, 2026, disclosing transactions in Aflac common stock dated September 16, 2026.

Shwetambri Chauhan | 18 September 2026

Equitable Holdings Director Sells 2,000 Shares

A Form 4 filed with the SEC on September 18, 2026, discloses that Craig C. MacKay, a director of Equitable Holdings, Inc. (NYSE:EQH), sold 2,000 shares of common stock on September 17, 2026.

Vinay Lochav | 18 September 2026

Generac Holdings Officer Files Form 4 Stock Transactions

Kyle Andrew Raabe, President of Home Power Generation at Generac Holdings Inc., filed a Form 4 on September 18, 2026, disclosing a series of open-market sales and a stock option exercise that occurred on September 17, 2026, under a pre-established Rule 10b5-1(c) trading plan.

Nitish Kishor | 18 September 2026

Viasat CFO Reports RSU Vesting and Tax Withholding

Garrett L. Chase, Senior Vice President and Chief Financial Officer of Viasat Inc. (NASDAQ:VSAT), filed a Form 4 on September 18, 2026, disclosing restricted stock unit vestings and related share withholdings that occurred on September 16 and 17, 2026.

Shwetambri Chauhan | 18 September 2026
Support

Hi! How can we help you today?

Loading…